Member Info for jmfw

According to Investing.com average daily volume(dv) some 312k. Only on 2 occasions since 1 Dec has the dv dropped below that. Shortiing has increased significantly since 4 Dec, & was 36% yesterday. Wow.

Whether one is in for long or short term the current trend is (very) uncomfortable. It will be interesting to see the impact the Foralumab news has on the sp. Can't help thinking there is an ulterior motive at play, but who knows. IMO the bod have certainly help create a degree of uncertaintity.

Ofcourse, the other quandry is Accustem. Not just initial value but how it will function as a business.

I've not followed this bb of late so all these (rhetorical) questions have probably been asked. Bit like navel gazing really until we get official news & not just a tv chat.

Sleepydave....agree, but official news is always the clincher. Too many conclusions have been reached on 'promising' situations that haven't materialised. In avacta's case much expectation has been built more by what has been desired & the joining of dots incorrectly, than by what we are/have been told by the Company.

In my case, I'm excited, but tempered accordingly.

Rumours aren't great. Only confirmation from an official source, or Company direct, carry any real weight. But we'll know within in a few days Wether(by) or not.

ta......sounds as if it could be 'lovely jubly' time

Yorkshire. is it Wetherby rumours? Wetherby rumours! or Wetherby rumours.

but they did buy in for the cancer side of the business. If, as suggested, they had done extensive research, covid wasn't on the horizon when they started theirs.

Livedata..."A highly scalable test device using readily available components and routine manufacturing processes has now been shown to have a sensitivity for coronavirus spike protein in laboratory samples better than 300 pg/ml which is in the range expected for spike protein in clinical samples."
From the last rns. One must draw their own conclusion, but it seems pretty clear to me.

If only the nasal swab being evaluated surely tech transfer is irrelevant. Presumably BBI developed/produced it, hence no tt.

Wkworld, what has AS promised & not delivered (so far)?

E&F, what was the timeline he was promoting & when exactly did he state it?

GMCC. No targets have ever been disclosed. I think the first 'the market' will hear about any use of affimers will be following the completion of any succesful trial.

GMCC, interesting link to Moderna pipeline. I particularly notice mRNA-1893 for zika......avct did it's own work on that virus back in 2016. Moderna extended their licensing with us in Feb 2019 & '1893' entered a clinical trial on 30 july 2019.

Obviously can't draw any conclusions, but interesting.

Doubt it's ours as need to swab both throat & nose.

Not understand Wyndrum. Ofcourse I could be wrong as not technical, but don't understand why TT will be required (for the swab) because BBI are developing it & then presumeably will manufacture. The saliva test is a different matter, although if BBI were to re-design I would ask the same question.

However, if there are to be multiple producers (for both lfd) TT to them will be necessary, I guess.

"I am delighted with the excellent progress that has been made with BBI Solutions in developing a scalable version of a lateral flow rapid SARS-CoV-2 antigen test"
What TT has to occur? BBI are developing the offering.

https://avacta.com/sars-cov-2-rapid-antigen-test-update/
Can someone offer enlightenment as I'm ignorant of the significance of this.
The diagnostic business unit has also made good progress on a number of other non-COVID-19 commercial opportunities and on putting in place an ISO13485 accredited quality system to support the future growth.
Picked out by an unmentionable ex contributor.

"It has been invited by NHS Test and Trace and the University of Oxford to participate in urgent research into the effectiveness of a new screening test. "
Urgent research... testing effectiveness of new screening test. Unless Innova rolling out an updated version it's unlikely to be theirs.

Thanks Dave.

Don't see ANY trades today. Can someone confirm whether this so. If correct, either a technical blip, or............?

WE already know this, but nice to see in public domain.